Clinical Trial Update: GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating GM-CSF to reverse immunoparalysis in pediatric sepsis-induced MODS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Sepsis

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome | Phase 3 | Status: COMPLETED